Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Other Working Capital Changes (2024 - 2025)

Historic Other Working Capital Changes for Prelude Therapeutics (PRLD) over the last 2 years, with Q3 2025 value amounting to -$287000.0.

  • Prelude Therapeutics' Other Working Capital Changes rose 9267.11% to -$287000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $957000.0, marking a year-over-year change of. This contributed to the annual value of -$1.1 million for FY2024, which is 16471.67% down from last year.
  • Latest data reveals that Prelude Therapeutics reported Other Working Capital Changes of -$287000.0 as of Q3 2025, which was up 9267.11% from $331000.0 recorded in Q2 2025.
  • In the past 5 years, Prelude Therapeutics' Other Working Capital Changes registered a high of $2.2 million during Q2 2024, and its lowest value of -$3.9 million during Q3 2024.